Amgen and Onyx Finally Agree to US$10.4 B Takeover
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 9 (Table of Contents)
Published: 6 Sep-2013
DOI: 10.3833/pdr.v2013.i9.1976 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Two months after making an unsolicited offer of US$120 per share for the company, Amgen has succeeded in its bid to acquire Onyx Pharmaceuticals in order to expand its portfolio of cancer drugs...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS